Selected research
Industry Research
Imipenem Industry Research Report 2026
Market perspective
The global Imipenem market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Imipenem is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Imipenem is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Imipenem is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Imipenem include Sun Pharmaceutical Industries, Haibin Pharmaceutical, Jiangxi Fushine Pharmaceutical, Savior Lifetec, HISUN Pharmaceutical and HISOAR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Imipenem market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Imipenem Market by Company
Sun Pharmaceutical Industries
Haibin Pharmaceutical
Jiangxi Fushine Pharmaceutical
Savior Lifetec
HISUN Pharmaceutical
HISOAR
Imipenem Segment by Type
Sterile Type
Non-sterile Type
Imipenem Segment by Application
Injection
Other
Imipenem Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Imipenem market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Imipenem and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Imipenem.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Imipenem manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Imipenem by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Imipenem in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sterile Type
- Non-sterile Type
Applications
- Injection
- Other
Companies covered
- Sun Pharmaceutical Industries
- Haibin Pharmaceutical
- Jiangxi Fushine Pharmaceutical
- Savior Lifetec
- HISUN Pharmaceutical
- HISOAR
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Imipenem Market Size (2021-2032)
- 2.2.2 Global Imipenem Sales (2021-2032)
- 2.2.3 Global Imipenem Market Average Price (2021-2032)
- 2.3 Imipenem by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Sterile Type
- 2.3.3 Non-sterile Type
- 2.4 Imipenem by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Injection
- 2.4.3 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Imipenem Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Imipenem Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Imipenem Revenue of Manufacturers (2021-2026)
- 3.4 Global Imipenem Average Price by Manufacturers (2021-2026)
- 3.5 Global Imipenem Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Imipenem, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Imipenem, Product Type & Application
- 3.8 Global Manufacturers of Imipenem, Established Date
- 3.9 Global Imipenem Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sun Pharmaceutical Industries
- 4.1.1 Sun Pharmaceutical Industries Company Information
- 4.1.2 Sun Pharmaceutical Industries Business Overview
- 4.1.3 Sun Pharmaceutical Industries Imipenem Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sun Pharmaceutical Industries Imipenem Product Portfolio
- 4.1.5 Sun Pharmaceutical Industries Recent Developments
- 4.2 Haibin Pharmaceutical
- 4.2.1 Haibin Pharmaceutical Company Information
- 4.2.2 Haibin Pharmaceutical Business Overview
- 4.2.3 Haibin Pharmaceutical Imipenem Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Haibin Pharmaceutical Imipenem Product Portfolio
- 4.2.5 Haibin Pharmaceutical Recent Developments
- 4.3 Jiangxi Fushine Pharmaceutical
- 4.3.1 Jiangxi Fushine Pharmaceutical Company Information
- 4.3.2 Jiangxi Fushine Pharmaceutical Business Overview
- 4.3.3 Jiangxi Fushine Pharmaceutical Imipenem Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangxi Fushine Pharmaceutical Imipenem Product Portfolio
- 4.3.5 Jiangxi Fushine Pharmaceutical Recent Developments
- 4.4 Savior Lifetec
- 4.4.1 Savior Lifetec Company Information
- 4.4.2 Savior Lifetec Business Overview
- 4.4.3 Savior Lifetec Imipenem Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Savior Lifetec Imipenem Product Portfolio
- 4.4.5 Savior Lifetec Recent Developments
- 4.5 HISUN Pharmaceutical
- 4.5.1 HISUN Pharmaceutical Company Information
- 4.5.2 HISUN Pharmaceutical Business Overview
- 4.5.3 HISUN Pharmaceutical Imipenem Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 HISUN Pharmaceutical Imipenem Product Portfolio
- 4.5.5 HISUN Pharmaceutical Recent Developments
- 4.6 HISOAR
- 4.6.1 HISOAR Company Information
- 4.6.2 HISOAR Business Overview
- 4.6.3 HISOAR Imipenem Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 HISOAR Imipenem Product Portfolio
- 4.6.5 HISOAR Recent Developments
5 Global Imipenem Market Scenario by Region
- 5.1 Global Imipenem Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Imipenem Sales by Region: 2021-2032
- 5.2.1 Global Imipenem Sales by Region: 2021-2026
- 5.2.2 Global Imipenem Sales by Region: 2027-2032
- 5.3 Global Imipenem Revenue by Region: 2021-2032
- 5.3.1 Global Imipenem Revenue by Region: 2021-2026
- 5.3.2 Global Imipenem Revenue by Region: 2027-2032
- 5.4 North America Imipenem Market Facts & Figures by Country
- 5.4.1 North America Imipenem Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Imipenem Sales by Country (2021-2032)
- 5.4.3 North America Imipenem Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Imipenem Market Facts & Figures by Country
- 5.5.1 Europe Imipenem Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Imipenem Sales by Country (2021-2032)
- 5.5.3 Europe Imipenem Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Imipenem Market Facts & Figures by Country
- 5.6.1 Asia Pacific Imipenem Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Imipenem Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Imipenem Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Imipenem Market Facts & Figures by Country
- 5.7.1 South America Imipenem Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Imipenem Sales by Country (2021-2032)
- 5.7.3 South America Imipenem Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Imipenem Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Imipenem Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Imipenem Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Imipenem Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Imipenem Sales by Type (2021-2032)
- 6.1.1 Global Imipenem Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Imipenem Sales Market Share by Type (2021-2032)
- 6.2 Global Imipenem Revenue by Type (2021-2032)
- 6.2.1 Global Imipenem Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Imipenem Revenue Market Share by Type (2021-2032)
- 6.3 Global Imipenem Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Imipenem Sales by Application (2021-2032)
- 7.1.1 Global Imipenem Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Imipenem Sales Market Share by Application (2021-2032)
- 7.2 Global Imipenem Revenue by Application (2021-2032)
- 7.2.1 Global Imipenem Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Imipenem Revenue Market Share by Application (2021-2032)
- 7.3 Global Imipenem Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Imipenem Value Chain Analysis
- 8.1.1 Imipenem Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Imipenem Production Mode & Process
- 8.2 Imipenem Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Imipenem Distributors
- 8.2.3 Imipenem Customers
9 Global Imipenem Analyzing Market Dynamics
- 9.1 Imipenem Industry Trends
- 9.2 Imipenem Industry Drivers
- 9.3 Imipenem Industry Opportunities and Challenges
- 9.4 Imipenem Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst